JPRN-jRCT2080220850未知2 期
Phase II Study of S-1, Oral Leucovorin, Oxaliplatin, and Bevacizumab Combination Therapy in patients with Untreated Metastatic Colorectal Cancer.
试验速览
- 阶段
- 2 期
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Adequate oral intake
- •At least one measurable lesion by RECIST criteria.
- •ECOG Performance status:0-1
排除标准
- •Serious drug hypersensitivity
- •Prior history of peripheral neuropathy
- •Simultaneously active double cancer
研究者
相似试验
已完成
2 期
Phase II study of oral S-1 plus oral leucovorin in patients with previously treated non-small-cell lung cancerPre-treated non-small cell lung cancerJPRN-UMIN000004568Protocol team for S-1 with leucovorin therapy32
Unknown
1 期
Phase I/II Study of SOL for Untreated Metastatic Colorectal CancerColorectal CancerNCT00524706Shizuoka Cancer Center42
已完成
2 期
Phase II study of S-1 plus oxaliplatin (130 mg/m2, every 3 weeks) for advanced gastric cancerJPRN-UMIN000016973Shizuoka Cancer Center25
未知
Unknown
A phase 1/2 trial of Oxaliplatin(L-OHP) + S-1 in patients with previously untreated advanced colorectal cancerColorectal cancerJPRN-jRCT2080220116Yakult Honsha Co.,Ltd.
已完成
1 期
A Phase I/II Study of S-1 and Oxaliplatin Combined With Radiation for Preoperative Locally Advanced Rectal CarcinomaColorectal CancerJPRN-UMIN000017450Japan Clinical Cancer Research Organization45